TrialFrontiers in immunology2024

Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial.

Khaled Baagar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.